# Evaluation of Reader Training Processes

> **NCT02051790** · PHASE4 · COMPLETED · sponsor: **Avid Radiopharmaceuticals** · enrollment: 241 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** florbetapir F 18

## Key facts

- **NCT ID:** NCT02051790
- **Lead sponsor:** Avid Radiopharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 241 (ACTUAL)
- **Last updated:** 2015-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02051790

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02051790, "Evaluation of Reader Training Processes". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02051790. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*